A new Northwestern Medicine study has demonstrated that a combination of two mutations makes a form of pediatric brain tumors more deadly.
The structure of spherical nucleic acids has the potential to improve the effectiveness of vaccines as well as cancer immunotherapies, according to a new study.
A relatively newer and more complex therapy for diffuse large B-cell lymphoma did not show improvement over the current standard of care, but provides important new context for how the cancer affects treatment options.
A drug called niraparib showed clinically relevant activity in women with relapsed ovarian cancer who had exhausted all previous treatment options, according to a recent study.
High doses of vitamin D, in combination with chemotherapy, may improve progression-free survival in patients with advanced colorectal cancer, according to a clinical trial published in JAMA.
A delegation from the National Comprehensive Cancer Network, including Northwestern oncology leaders, recently met with health leaders in Bolivia to begin generating cancer treatment recommendations to fit the country’s unique needs.
Northwestern scientists recently identified a new protein complex that is upregulated in acute myeloid leukemia, potentially explaining why current therapies are often ineffective.
More than 450 scientists, trainees, students and faculty presented posters and abstracts at Feinberg’s 15th Annual Lewis Landsberg Research day — the largest celebration of scientific investigation at Feinberg to date.
Kathleen Green, PhD, the Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and professor of Dermatology, has been named the winner for the 2019 Tripartite Legacy Faculty Prize in Translational Science and Education.
A new study has uncovered a key mechanism underlying the control of a co-factor that is essential for all cells to grow and divide, and which may also play a key role in cancer cell growth.